October 24, 2020
Article
The hospital found just 2 cases in their first 12 weeks were borne in the facility. A study author provides insight.
Video
A cross-specialty collaboration to mitigate inpatient cases of opioid use disorder has had early success; developers want to grow it.
An investigator shares detail into how the neutralizing, immune-signaling molecule may provide continued success against the virus.
October 23, 2020
Ravina Kullar, PharmD, MPH, reflects on rapid advances in COVID-19 treatment understanding during IDWeek 2020.
New data suggest collaboration between hospital prescribers and stewardship teams is still not perfected.
New data show the pandemic, and a lack of efficacious therapies, did harm to 4 years' worth of stewardship.
Investigators wanted to examine spontaneously reported adverse events and whether they were cause for concern.
The conclusion to the independent safety review punctuates a 50-day period of scrutiny and discussion around 2 non-fatal adverse events reported in patients.
Here is a look at the patterns within the variety of symptoms and presentations during physician exams.
A presenting author offers greater study insights into this novel therapy for the treatment of serious infections.
